UBS Group AG
UBS Group AG (UBS) Financial Performance & Income Statement Overview
Explore the financials of UBS Group AG (UBS), including yearly and quarterly data on income, cash flow, and balance sheets.
UBS Group AG (UBS) Income Statement & Financial Overview
Access detailed annual and quarterly income data for UBS Group AG UBS financial performance.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $11.38B | $11.06B | $11.46B | $11.85B |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $11.38B | $11.06B | $11.46B | $11.85B |
| Gross Profit Ratio | $1.00 | $1.00 | $1.00 | $1.00 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $7.02B | $8.11B | $6.38B | $8.89B |
| Operating Expenses | $0.00 | $11.06B | $7.94B | $10.49B |
| Total Costs & Expenses | $0.00 | $11.06B | $7.94B | $10.49B |
| Interest Income | $8.58B | $9.72B | $10.81B | $10.85B |
| Interest Expense | $6.95B | $7.88B | $9.02B | $9.32B |
| Depreciation & Amortization | $861.00M | $850.00M | $1.006B | $903.00M |
| EBITDA | $0.00 | $0.00 | $4.53B | $2.26B |
| EBITDA Ratio | $0.00 | $0.00 | $0.40 | $0.19 |
| Operating Income | $0.00 | $0.00 | $3.53B | $1.36B |
| Operating Income Ratio | $0.00 | $0.00 | $0.31 | $0.11 |
| Other Income/Expenses (Net) | $2.13B | $1.05B | -$1.60B | $110.00M |
| Income Before Tax | $2.13B | $1.05B | $1.93B | $1.47B |
| Income Before Tax Ratio | $0.19 | $0.09 | $0.17 | $0.12 |
| Income Tax Expense | $430.00M | $268.00M | $502.00M | $293.00M |
| Net Income | $1.69B | $770.00M | $1.43B | $1.14B |
| Net Income Ratio | $0.15 | $0.07 | $0.12 | $0.10 |
| EPS | $0.53 | $0.24 | $0.39 | $0.32 |
| Diluted EPS | $0.51 | $0.23 | $0.37 | $0.30 |
| Weighted Avg Shares Outstanding | $3.20B | $3.18B | $3.20B | $3.21B |
| Weighted Avg Shares Outstanding (Diluted) | $3.33B | $3.34B | $3.34B | $3.36B |
Over the past four quarters, UBS Group AG demonstrated steady revenue growth, increasing from $11.85B in Q2 2024 to $11.38B in Q1 2025. Operating income reached $0.00 in Q1 2025, maintaining a consistent N/A margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $0.00, reflecting operational efficiency. Net income rose to $1.69B, with EPS at $0.53. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan